TYZEKA vs VIREAD

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 2, 2026·How we rate

Possible drug interaction. TYZEKA and VIREAD are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	TYZEKA	VIREAD
Rating	70/100	72/100
Pharmacy pays	—	~$9.49 /30
Type	RX	RX
Active ingredient	TELBIVUDINE	TENOFOVIR DISOPROXIL FUMARATE
Manufacturer	Novartis	Gilead Sciences Inc
Dosage forms	Solution, Tablet	Powder, Tablet
Drug class	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Boxed warning	None	Boxed warning
Treats	Chronic Hepatitis B	Chronic Hepatitis B, Acquired Immunodeficiency Syndrome

tyzeka viread

Rating

70/100

72/100

Pharmacy pays

—

~$9.49 /30

Type

Active ingredient

TELBIVUDINE

TENOFOVIR DISOPROXIL FUMARATE

Manufacturer

Novartis

Gilead Sciences Inc

Dosage forms

Solution, Tablet

Powder, Tablet

Drug class

—

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Boxed warning

None

Boxed warning

Treats

Chronic Hepatitis B

Chronic Hepatitis B, Acquired Immunodeficiency Syndrome

Frequently asked questions

Which is better-rated, Tyzeka or Viread?

By our independent rating, Viread scores higher — 3.6 vs 3.5 out of 5 for Tyzeka. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Tyzeka and Viread?

Tyzeka contains Telbivudine, while Viread contains Tenofovir Disoproxil Fumarate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.